trial · primary record
Avelumab
Endometrial Cancer
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 8 |
| Primary completion | 2029-08-31 |
| Primary endpoint | Progression Free Survival at 6 months (PFS6) |
| Registry ID | NCT06518564 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:36.041Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06518564
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.